Shopping Cart
- Remove All
Your shopping cart is currently empty
Dopamine D4 receptor antagonist-1 can be used in schizophrenia study. Dopamine D4 receptor antagonist-1 is a selective antagonist of Dopamine D4 receptor (DRD4). The Ki value of Dopamine D4 receptor antagonist-1 for Hd4.2 is 9.0 nM [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks |
| Description | Dopamine D4 receptor antagonist-1 can be used in schizophrenia study. Dopamine D4 receptor antagonist-1 is a selective antagonist of Dopamine D4 receptor (DRD4). The Ki value of Dopamine D4 receptor antagonist-1 for Hd4.2 is 9.0 nM [1]. |
| Targets&IC50 | D4.2 receptor (human):9.0 nM (Ki) |
| In vivo | Dopamine D4 receptor antagonist-1, administered intraperitoneally at a dosage of 10 mg/kg in a single dose, exhibits an inhibitory effect on catecholaminergic systems, specifically leading to increased dopamine (DOPA) accumulation in the hippocampus, with no significant effect on the striatum [1]. This observation was made in male Long-Evans rats weighing 180-250 g, dopamine D4 receptor locus knockout mice (D4 KO), and wild-type rats (WT). |
| Molecular Weight | 326.82 |
| Formula | C18H19ClN4 |
| Cas No. | 444724-92-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.